PET/CT after therapy avoids surgery for head, neck cancer
Using PET/CT scans to assess response to therapy can help patients with head...Read more on AuntMinnie.comRelated Reading: 3-month PET/CT helps track oropharyngeal cancer Interrupted radiation therapy risks cancer recurrence PET/CT details hint at survival of head and neck cancer patients Oral HPV infection increasing in young men PET/CT prevents dissections for head and neck cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 24, 2016 Category: Radiology Source Type: news

ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer
By Stacy Simon The American Cancer Society has released a new Head and Neck Survivorship Care Guideline to help survivors of head and neck cancer and their primary care providers better manage their long-term care. The guideline addresses cancers of the oral cavity, tongue, lip, pharynx (throat), and larynx (voice box). Recommendations in the guideline may also apply to cancers of the salivary glands, nasal and paranasal sinuses, and nasopharynx. But it does not address cancers of the brain, thyroid, or esophagus because they are very different in terms of symptoms and treatment. RESOURCES: Head and Neck Cancer Surv...
Source: American Cancer Society :: News and Features - March 23, 2016 Category: Cancer & Oncology Tags: Oral Cavity and Oropharyngeal Cancer Laryngeal and Hypopharyngeal Cancer Salivary Gland Cancer Nasal Cavity and Paranasal Sinus Cancer Nasopharyngeal Cancer Source Type: news

3-month PET/CT helps track oropharyngeal cancer
A three-month follow-up PET/CT scan is very helpful for detecting the recurrence...Read more on AuntMinnie.comRelated Reading: Interrupted radiation therapy risks cancer recurrence PET/CT details hint at survival of head and neck cancer patients Oral HPV infection increasing in young men PET/CT prevents dissections for head and neck cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 1, 2016 Category: Radiology Source Type: news

NIDCR Science News - Feb 2016
NIDCR Science News for February 2016 Scientists Discover Stem Cells Capable of Repairing Skull, Face BonesFeb 1, 2016 - University of Rochester Breakthrough in Generating Embryonic Cells That Are Critical for Human Health​Feb 3, 2016 - University of California, Riverside​ A "Crain’s 2016 Health Care Hero" Hails from School of Dental Medicine at Case Western Reserve University​Feb 3, 2016 - Case Western Reserve University  NIH Seeks Research Applications to Study Zika in Pregnancy, Developing FetusFeb 5, 2016 - National Institutes of Health Possible Marker for Recurring...
Source: NIDCR Science News - February 29, 2016 Category: Dentistry Source Type: news

HPV Throat Cancer in Men Increasing -- Link to Oral Sex?HPV Throat Cancer in Men Increasing -- Link to Oral Sex?
New data show that men are more likely to become infected with oral HPV and are less likely to clear these oral infections. Does this explain the higher incidence of HPV oropharyngeal cancer? Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Staging System for HPV-Positive Oropharyngeal CancerNew Staging System for HPV-Positive Oropharyngeal Cancer
Researchers propose a new staging system for HPV-positive oropharyngeal cancer that could help improve prediction of survival, treatment selection, and recruitment into clinical trials. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 25, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCCN Is 'Vague,' So Study Clarifies H&N Cancer Follow-upNCCN Is 'Vague,' So Study Clarifies H&N Cancer Follow-up
HPV-positive oropharyngeal cancers are becoming less catastrophic than the head and neck cancers of past decades, and need their own guidance related to surveillance. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Study determines key recurrence detection time for oropharyngeal cancer
(American Society for Radiation Oncology) For patients treated with definitive radiation therapy (RT) for oropharyngeal cancer caused by human papillomavirus (HPV), the majority of recurrences can be detected by post-treatment imaging at three months and physical exams during the six months following treatment, according to research presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 18, 2016 Category: Cancer & Oncology Source Type: news

New staging for HPV-related oropharyngeal cancer
Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging system does not adequately account for biological and clinical differences between HPV-positive OPC and HPV-negative OPC, commonly caused by alcohol and tobacco use, say researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 16, 2016 Category: Science Source Type: news

MD Anderson researchers propose new staging for HPV-related oropharyngeal cancer
(University of Texas M. D. Anderson Cancer Center) Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging system does not adequately account for biological and clinical differences between HPV-positive OPC and HPV-negative OPC, commonly caused by alcohol and tobacco use. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2016 Category: Cancer & Oncology Source Type: news

MD Anderson Researchers Propose New Staging for HPV-Related Oropharyngeal Cancer (The University of Texas MD Anderson Cancer Center)
Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging system does not adequately account for biological and clinical differences between HPV-positive OPC and HPV-negative OPC, commonly caused by alcohol and tobacco use. With rates of HPV-related OPC rising rapidly, researchers at The University of Texas MD Anderson Cancer Center propose a new staging system to more accurately predict patient outcomes and iden... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - February 16, 2016 Category: Cancer & Oncology Source Type: news

Possible marker for recurring HPV-linked oropharyngeal cancers
(Johns Hopkins Medicine) A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at The Johns Hopkins University. A report on the study is published in the February issue of Cancer Prevention Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2016 Category: Global & Universal Source Type: news

Duke Cancer Institute Joins National Endorsement of HPV Vaccination
Contact: Sarah Avery Phone: 919-660-1306 Email: sarah.avery@duke.edu https://www.dukehealth.org FOR IMMEDIATE RELEASE on Wednesday, Jan. 27, 2016  DURHAM, N.C. – In response to low national vaccination rates for the human papillomavirus (HPV), the Duke Cancer Institute has joined all 68 other top U.S. cancer centers in issuing a statement urging increased HPV vaccinations to prevent cancer.  These institutions collectively recognize insufficient vaccination as a public health threat and call upon the nations’ physicians, parents and young adults to take advantage of a rare opportunity to prevent many types of cancer....
Source: DukeHealth.org: Duke Health Features - January 28, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Cancer Centers Urge More People to Get the HPV Vaccine
By Stacy Simon The American Cancer Society is supporting a call-to-action from dozens of National Cancer Institute-designated Cancer Centers across the US urging action to increase vaccination against human papillomavirus (HPV). HPV vaccines protect against high-risk types of the virus that cause most cervical cancers. The virus is also linked to cancers of the vulva, vagina, penis, anus, and throat. Despite this, vaccination rates across the US remain low. According to the Centers for Disease Control and Prevention (CDC), only 40% of girls and 21% of boys in the US have received all 3 doses of the vaccine. The CDC recomme...
Source: American Cancer Society :: News and Features - January 27, 2016 Category: Cancer & Oncology Tags: Cervical Cancer Oral Cavity and Oropharyngeal Cancer Anal Cancer Vulvar Cancer Vaginal Cancer Source Type: news